SABBY 13G BLRX 03.14.14

Company

BioLineRx Ltd.

Filed

March 14, 2014

Accession Number

0001535610-14-000047

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →